Premature ovarian failure.
The diagnosis of premature ovarian failure is based on the finding of amenorrhoea before age 40 associated with follicle-stimulating hormone levels in the menopausal range. Screening for associated autoimmune disorders and karyotyping, particularly in early onset disease, constitute part of the diagnostic work up. There is no role for ovarian biopsy or ultrasound in making the diagnosis. Management essentially involves hormone replacement and infertility treatment, the most successful being assisted conception with donated oocytes. Embryo cryopreservation, ovarian tissue or oocyte cryopreservation and in vitro maturation of oocytes hold promise in cases where ovarian failure is foreseeable as in women undergoing cancer treatments.
Goswami
Deepti
D
Department of Obstetrics and Gynaecology, Maulana Azad Medical College, New Delhi, India.
Conway
Gerard S
GS
D015551:Autoimmunity; D004314:Down Syndrome / Q000150:complications; D005260:Female; D030342:Genetic Diseases, Inborn / Q000150:complications; D040181:Genetic Diseases, X-Linked / Q000150:complications; D020249:Hormone Replacement Therapy; D006801:Humans; D007247:Infertility, Female / Q000209:etiology / Q000523:psychology; D016649:Primary Ovarian Insufficiency / Q000175:diagnosis* / Q000209:etiology* / Q000235:genetics / Q000628:therapy; D014424:Turner Syndrome / Q000150:complications